Abstract: Nonenzymatic glycation of proteins has been implicated in various diabetic complications and age-related disorders. Proteins undergo glycation at the N-terminus or at the e-amino group of lysine residues. Glycation of proteins proceeds through the stages of Schiff base formation, conversion to ketoamine product and advanced glycation end products. Gramicidin S, which has two ornithine residues, was used as a model system to study the various stages of glycation of proteins using electrospray ionization mass spectrometry. The 
Nonenzymatic glycosylation or glycation of proteins is a common post-translational modification of proteins, resulting from reactions between glucose and amino groups of proteins (1) . The initially formed Schiff base adduct undergoes an irreversible Amadori rearrangement to a ketoamine product (2) . Glycation of proteins has been linked to many pathological complications of diabetes mellitusretinopathy, neuropathy and nephropathy (3,4), Alzheimer's disease (5) and aging (6) . Several reports are available on the glycation of various proteins, notably albumin (7) hemoglobin A (8) , collagen (9) , RNase A (10) and several erythrocytic proteins (11) . Various factors have been implicated in influencing the site and extent of glycation. The site selectivity of glycation in proteins has been suggested to be a consequence of the Amadori rearrangement ability of the glycation sites (12) , which in turn depends on the microenvironment. The effect of three-dimensional structure (13) on the extent of glycation has also been reported.
The importance of buffer in influencing ketoamine formation is well studied (14) . At the later stages of the glycation reaction, oxidative cleavage of the sugar moiety leads to the formation of AGEs such as carboxymethyllysine (CML) (15) and pentosidine (6) . CML formation is catalyzed under oxidative conditions (16) . Formation of cleavage products such as glyoxal, methylglyoxal and 3-deoxyglucosone at the early stages of glycation has also been reported (17) .
Advanced glycation products such as carboxymethyllysine and carboxyethyllysine have been implicated as important intermediates in protein cross-linking reactions (18) . The accumulation of AGEs has been correlated with aging and severity of diabetes. The CML adduct in proteins has been established in vivo in human tissues. A wealth of experimental evidence supports the hypothesis that AGEs have an important role in the development of diabetic complications and other diseases (19) . Therefore, it is important to develop methods that can inhibit or reverse glycation at the initial stages.
In this report we describe the use of gramicidin S, a cyclic decapeptide, as a model for the study of protein glycation and its reversal in the presence of nucleophilic amines. 2 ] is a structurally well-defined peptide which is constrained to adopt an antiparallel a sheet structure with cyclization facilitated by two d-Phe-Pro a-turns. In this conformation, the alkylamino side chains on the two ornithine residues lie on the same phase of the a-sheet in close proximity (20, 21) . We show using electrospray ionization mass spectrometry (ESI-MS), multiple glycation and formation of advanced glycation products in gramicidin S and also rapid reversal of Schiff base using hydrazines such as hydroxylamine, aminoguanidine and isonicotinic acid hydrazide.
Materials and Methods
Gramicidin S hydrochloride and isonicotinic acid hydrazide 
Oxime formation
Gramicidin incubated with glucose for 24 h was treated with excess hydroxylamine. The mixture was heated to 708C in a water bath for 1 h and then analyzed using ESI-MS.
A similar procedure was followed for the preparation of the aminoguanidine derivative.
Results

Glycation of gramicidin S
The ESI-MS spectrum ( The mass spectrum of the sample incubated for 100 days (Fig. 1c) shows the presence of advanced glycation products CML [F, H] and CEL [G, I]. After 140 days of incubation, the major species observed (Fig. 1d) was the triply glycated species D. Significant amounts of species E (Table 1) , in which there is double glycation on both the ornithine residues, were also observed. Species D and E were retained on treatment with hydroxylamine indicating that they are ketoamine adducts. At this time, singly glycated gramicidin was completely absent.
Reversal of glycation in gramicidin S
Addition of hydroxylamine to the gramicidin sample after 6 h of incubation with glucose ( Fig. 3a) resulted in complete deglycation of the glucose adducts (Fig. 3b) . Similarly, on passing through a reverse-phase C 18 liquid chromatography column complete reversal of glycation was observed.
Treatments with INH or aminoguanidine (Fig. 3c ) also caused deglycation of the glucose adduct but hydroxylamine was found to be more effective. Prolonged incubation of the glycated peptide with INH or aminoguanidine showed that deglycation using these reagents improved with time. In this study, quantitation of ketoamine product is also shown using ESI-MS. On treatment with hydroxylamine, partial deglycation was observed in samples incubated for 12 and 24 h. This would imply that the Amadori rearrangement has taken place to some extent at this time to give the ketoamine product, which does not undergo deglycation with hydroxylamine. The glycated product obtained after 24 h of incubation with glucose was treated with excess hydroxylamine and warmed. The glycated adducts formed the corresponding oxime, confirming that this was indeed the ketoamine (Fig. 2) . Aminoguanidine also formed the corresponding derivative showing that the hydrazines can be used to differentiate the two stages of glycation.
Earlier studies used 2,4-dinitrophenylhydrazine (29) The Amadori rearrangement of the bisglucose adduct (two glucose molecules bound to the same ornitihine residue) was found to be faster than that of mono adduct.
This could presumably be due to the formation of immonium ion in the Schiff base of bis-adduct (which is the rate limiting step in the Amadori rearrangement under the reaction conditions) which facilitates the formation of the enolamine and ketoamine (Fig. 4) . The ESI-MS of the sample in which gramicidin S was incubated with glucose for 100 days (Fig. 1c) reveals that the major species is the triply glycated gramicidin S (D). Significant amounts of advanced glycation end products CML (F, H) and CEL (G, I) of the species C and D were also observed. The pH conditions used in this study (pH 8.5) facilitate the formation of CML. The rate of formation of CML from the ketoamine product of N-formyl-N-fructoselysine is reported to be higher at higher pH (15) . This is analogous to the oxidative degradation of sugars in alkali. Oxidative degradation of sugars is known to proceed by a free radical mechanism (32).
The ESI-MS spectrum of the sample incubated for 140 days (Fig. 1d) Table 1 .
Shakkottai et al . Gramicidin S: A peptide model for glycation in which four glucose molecules are bound to the peptide.
A maximum of four molecules of glucose can be bound to the peptide when both the ornithines are bound to two glucose residues. Observation of species E implies diglycation on both the ornithine residues of the peptide, which may be facilitated by the presence of two ornithine groups in the peptide at proximal positions. The rate of formation of E was found to be very slow which could be due to the reduction in catalytic effect of the proximal ornithine residue, which is diglycated.
Reversal of glycation
The initial glycation product is a Schiff base adduct Although there is a competing reaction between the free sugar in the reaction mixture and the hydroxylamine, the rate of transglycosylation is higher than the reaction of the free sugar, resulting in effective deglycation with hydroxylamine. Indeed, the rate of nucleophilic attack of semicarbazide on Schiff bases has been shown to be several orders of magnitude more rapid than the attack on the free aldehydes (Fig. 7) . This large rate difference has been attributed to the greater basicity of the Schiff base compared with the aldehydes (46). Figure 6 . Reactions of aminoguanidine with the carbonyl compounds at the various stages of protein glycation (32, 34 Figure 7 . Nucleophilic addition of semicarbazide to aldehyde and Schiff base (46) .
